Product Information
POTASSIUM CIT-CITRIC ACID SOLN is a generic product labeled by PAI Holdings LLC, priced at $0.0517 per ML under NDC 00121067616. Its NADAC has been published 568 times since Aug 19, 2015.
Strength
334; 1100 mg/5mL; mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121067616
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CITRIC ACID MONOHYDRATE; POTASSIUM CITRATEApproval Type
Unapproved
On Market Since
10/7/1997
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CIT-CITRIC ACID SOLN has been published 568 times since Aug 19, 2015, and over the history we have for it it has declined 29.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0517 per ML |
|---|---|
| All-time high | $0.0842 (Sep 12, 2018) |
| All-time low | $0.0367 (Aug 21, 2024) |
| 52-week high | $0.0541 |
| 52-week low | $0.0414 |
| Median price | $0.0597 |
| Average price | $0.0592 |
| Largest weekly change | +58.3% (Sep 18, 2024) |
| Weeks tracked | 568 |
| Tracking since | Aug 19, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Potassium Citrate and Citric Acid Monohydrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Citrate and Citric Acid Monohydrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CIT-CITRIC ACID SOLN?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CIT-CITRIC ACID SOLN, manufactured by PAI Holdings LLC, is $0.0517 per ML (NDC 00121067616), effective Sep 30, 2026.
How has the price of POTASSIUM CIT-CITRIC ACID SOLN changed over time?
Over the history we have for it, the NADAC for POTASSIUM CIT-CITRIC ACID SOLN has declined 29.7%. It has been tracked across 568 weekly CMS publications since Aug 19, 2015.
What are the highest and lowest recorded NADAC prices for POTASSIUM CIT-CITRIC ACID SOLN?
Since Aug 19, 2015, the NADAC for POTASSIUM CIT-CITRIC ACID SOLN has ranged from a low of $0.0367 (Aug 21, 2024) to a high of $0.0842 (Sep 12, 2018), with a median of $0.0597 per ML.
Are there cheaper alternatives to POTASSIUM CIT-CITRIC ACID SOLN?
No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CIT-CITRIC ACID SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CIT-CITRIC ACID SOLN?
POTASSIUM CIT-CITRIC ACID SOLN (NDC 00121067616) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.